PASQUALI, LIVIA
 Distribuzione geografica
Continente #
NA - Nord America 11.086
AS - Asia 5.587
EU - Europa 4.332
SA - Sud America 695
AF - Africa 231
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.966
Nazione #
US - Stati Uniti d'America 10.759
SG - Singapore 1.752
IT - Italia 1.749
CN - Cina 1.742
HK - Hong Kong 789
BR - Brasile 582
SE - Svezia 495
DE - Germania 477
VN - Vietnam 406
BG - Bulgaria 319
CA - Canada 271
GB - Regno Unito 256
TR - Turchia 240
FI - Finlandia 200
FR - Francia 183
IN - India 177
UA - Ucraina 160
RU - Federazione Russa 145
AT - Austria 110
JP - Giappone 110
KR - Corea 93
CI - Costa d'Avorio 86
CH - Svizzera 68
BD - Bangladesh 52
AR - Argentina 44
SN - Senegal 44
IQ - Iraq 34
NL - Olanda 33
PL - Polonia 32
MX - Messico 31
ID - Indonesia 25
ES - Italia 23
NG - Nigeria 22
ZA - Sudafrica 21
AU - Australia 19
SA - Arabia Saudita 18
BE - Belgio 16
EC - Ecuador 16
PK - Pakistan 16
UZ - Uzbekistan 16
TW - Taiwan 15
NZ - Nuova Zelanda 14
VE - Venezuela 14
MA - Marocco 13
MY - Malesia 13
EG - Egitto 12
IR - Iran 11
CO - Colombia 10
IE - Irlanda 10
PE - Perù 9
BJ - Benin 8
JO - Giordania 8
LB - Libano 8
LT - Lituania 8
PH - Filippine 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
GR - Grecia 6
KE - Kenya 6
TN - Tunisia 6
HU - Ungheria 5
IL - Israele 5
PA - Panama 5
PS - Palestinian Territory 5
PY - Paraguay 5
RS - Serbia 5
TH - Thailandia 5
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
KZ - Kazakistan 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LY - Libia 3
ME - Montenegro 3
NP - Nepal 3
TT - Trinidad e Tobago 3
AL - Albania 2
BO - Bolivia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
MD - Moldavia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
Totale 21.949
Città #
Woodbridge 1.095
Ashburn 998
Singapore 951
Ann Arbor 842
Hong Kong 773
Santa Clara 661
Shanghai 631
Houston 627
Chandler 591
San Jose 530
Fairfield 522
Dallas 473
Serra 458
Sofia 315
Milan 314
Beijing 304
Wilmington 255
New York 246
Seattle 225
Ottawa 206
Jacksonville 204
Cambridge 195
Boardman 174
Izmir 166
Los Angeles 164
Princeton 142
Florence 135
Lawrence 127
Lauterbourg 119
Medford 117
Nanjing 112
Tokyo 100
Vienna 96
Livorno 92
Ho Chi Minh City 87
Abidjan 86
Seoul 85
Hefei 83
Des Moines 74
Hanoi 74
Dong Ket 66
Munich 66
Pisa 66
Rome 64
Nanchang 58
Buffalo 56
Council Bluffs 55
London 55
Bern 54
Helsinki 53
Istanbul 51
Redondo Beach 50
Columbus 48
Dearborn 47
The Dalles 46
São Paulo 44
Dakar 43
Frankfurt am Main 43
Bremen 42
Ogden 41
Jüchen 40
Redwood City 38
Fondi 36
Pune 32
Warsaw 30
Falls Church 29
San Diego 29
Düsseldorf 28
Boulder 27
Rio de Janeiro 27
Turku 26
Orem 25
Lancaster 24
Shenyang 24
Hangzhou 23
Hebei 23
Kunming 22
Lagos 22
Phoenix 22
Changsha 21
Chicago 20
Norwalk 18
Tianjin 18
Chennai 17
Da Nang 17
Toronto 16
Washington 16
Amsterdam 15
Detroit 15
Guangzhou 15
Baghdad 14
Belo Horizonte 14
Brooklyn 14
Brussels 14
Dhaka 14
Stockholm 14
Tashkent 14
Atlanta 13
Hyderabad 13
Jakarta 13
Totale 15.349
Nome #
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 780
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 365
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease 357
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 239
The role of mitochondria in stem cell biology 231
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine 228
Clinical Trials for Neuroprotection in ALS 224
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 221
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 218
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 218
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 218
Oxidative stress modulation in neurodegenerative diseases 214
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 204
The Italian multiple sclerosis register 203
Astrocyte-neuron interactions in neurological disorders 199
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. 198
The Role of Mitochondria in StemCell Biology 196
MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss 196
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 193
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 189
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 188
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 185
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis. 184
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 183
A case of comorbidity between multiple sclerosis and multiple system atrophy 183
Impaired oxidative metabolism in exercising muscle from ALS patients. 183
Occurrence of IgG oligoclonal bands in upper motor neuron disease: just by chance? 183
Sustained wakefulness combined with blood alcohol legal concentrations: effects on car driving performance. 182
Clinical and demographic features of multiple sclerosis in an Italian register: a cross-sectional ecologic study 182
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 181
H-MTTFA muscle levels in mitochondrial myopathies. 180
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) 179
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 178
Does autophagy worsen or improve the survival of dopaminergic neurons? 177
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 177
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 177
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus 176
Lack of α1b-adrenergic receptor protects against epileptic seizures 176
Plasma redox and inflammatory patterns during major depressive episodes: A cross-sectional investigation in elderly patients with mood disorders 176
The role of mitochondria in stem cell biology 176
Predictive factors of thyroid disease during sustained INF-ß therapy in 106 multiple sclerosis patients 174
Plasmatic oxidative stress biomarkers in multiple sclerosis: Relation with clinical and demographic characteristics. 174
Role of autophagy during methamphetamine neurotoxicity 173
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy 171
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 170
Very late onset multiple sclerosis likely associated with restless legs syndrome. A case report. 170
Intracellular pathways underlying the effects of lithium 169
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 169
Multiple Sclerosis and Neurofibromatosis type1: case report 168
Profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis: a clinical and laboratory study. 167
Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity 166
Alpha-synuclein and autophagy as common steps in neurodegeneration 165
Metabolic and muscle adaptation to aerobic training in CPEO patients. 164
Signs and symptoms of COVID-19 in patients with multiple sclerosis 161
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine 161
Autophagy, lithium, and amyotrophic lateral sclerosis 158
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 155
Facio-scapulo-humeral muscular dystrophy in North-West Tuscany: A clinically and molecularly based epidemiological study 154
Do Thyroid autoimmunity and dysfunction predict clinical outcome of multiple sclerosis patients trated with IFN-β? 153
Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test 153
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies. 151
Molecular diagnostics and mitochondrial dysfunction: a future perspective 151
Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model. 151
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 151
Malattie neurologiche in gravidanza 147
Limb girdle muscular dystrophy type 2a associated with epilepsy: a case report. 147
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 147
Cell To Cell Spreading Of Misfolded Proteins As A Therapeutic Target In Motor Neuron Disease. 147
Miopatie tossiche e da farmaci 146
I farmaci inibitori delle colinesterasi nel trattamento dei disturbi psichici e comportamentali nella malattia di Azheimer: focus su galantamina 145
Oxidative stress in myotonic dystrophy type 1 144
Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation 144
Pathways of methamphetamine toxicity 144
High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers 144
Effetti psichici e comportamentali dei farmaci antiepilettici nell’adulto 143
H-MTTFA muscle levels in mitochondrial myopathies 143
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut 143
Sensory axonal polyneuropathy in a patient with Systemic capillary leak syndrome (Clarkson disease): a case report. 142
Gastric emptying in myotonic dystrophic patients. 141
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate. 141
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 140
Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart A Comparison with the Parkinsonism-Inducing Neurotoxin MPTP 140
Frederich’s ataxia: a case report. 139
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients 139
Kennedy’s disease: a case report. 138
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 138
Epidemiology of facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based revisitation. 137
The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. 137
Relation between cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in multiple sclerosis 136
PLASMATIC AND CEREBROSPINAL FLUID OXIDATIVE STRESS BIOMARKERS IN ACUTE AND CHRONIC POLYRADICULONEUROPATHIES 135
Cardiomiopatia dilatativa familiare associata a miopatia 134
Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients 134
Effects of lithium administration on oxidative stress markers in amyotrophic lateral sclerosis patients 134
Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions 133
Complicanze gastrointestinali in pazienti neurologici trattati con glucocorticoidi: terapia con gli inibitori di pompa protonica 133
Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis 133
Lithium therapy is able to reduce oxidative stress in amyotrophic lateral sclerosis patients 133
Sudden death in epilepsy: Two case reports 132
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 132
Magnetization Transfer Imaging Of Cortical Motor System In Als Patients At Early Stage of Disease 131
Totale 17.612
Categoria #
all - tutte 58.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.425 17 105 19 68 283 196 50 102 78 45 92 370
2022/20232.019 195 248 138 194 228 271 31 145 336 18 192 23
2023/20241.563 184 155 249 112 205 279 60 29 31 53 76 130
2024/20254.888 70 204 41 256 508 441 735 222 435 574 495 907
2025/20265.134 320 522 432 340 557 449 836 206 258 396 743 75
2026/202721 21 0 0 0 0 0 0 0 0 0 0 0
Totale 22.203